| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €6.85B | −3.1% |
| Gross Profit | €2.22B | −6.6% |
| EBITDA | €1.20B | −6.5% |
| Net Income | -€5.0M | −102.6% |
| Diluted EPS | -€0.05 | −102.7% |
| Free Cash Flow | €332.0M | −35.3% |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| Ratio | 2023 | 2024 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Margins | ||||
| Gross Margin | 33.62% | 32.41% | 25% | |
| Operating Margin | 7.74% | 6.88% | 25% | |
| EBITDA Margin | 18.20% | 17.57% | 25% | |
| NOPAT Margin | 3.92% | 0.00% | 25% | |
| Net Margin | 2.73% | −0.07% | 25% | |
| FCF Margin | 7.26% | 4.85% | 25% | |
| FCFF Margin | 8.62% | 4.85% | 25% | |
| FCFE Margin | −13.31% | 1.18% | 75% | |
| OCF Margin | 18.05% | 12.28% | 25% | |
| Gross Profitability | 18.42% | 17.93% | 25% | |
| Capex Intensity | 10.79% | 7.43% | 25% | |
| ▸Returns on Capital · 3 ratios | ||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||
| ▸Earnings quality · 6 ratios | ||||
| ▸Liquidity & coverage · 6 ratios | ||||
| ▸Working capital · 8 ratios | ||||
| ▸Capital allocation · 3 ratios | ||||
| ▸Other · 1 ratios | ||||
The five drivers multiply to -0.1% vs reported ROE -0.1%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2023 | 2024 |
|---|---|---|
| Revenue | €7.07B | €6.85B |
| YoY % | -3.1% | |
| Cost of Revenue | €4.69B | €4.63B |
| YoY % | -1.3% | |
| Gross Profit | €2.38B | €2.22B |
| YoY % | -6.6% | |
| R&D Expense | €339.0M | €342.0M |
| YoY % | +0.9% | |
| Selling & Marketing Expense | €296.0M | €308.0M |
| YoY % | +4.1% | |
| SG&A Expense | €521.0M | €697.0M |
| YoY % | +33.8% | |
| Operating Income | €547.0M | €471.0M |
| YoY % | -13.9% | |
| Interest Expense | €190.0M | €113.0M |
| YoY % | -40.5% | |
| Interest & Investment Income | €81.0M | €22.0M |
| YoY % | -72.8% | |
| Equity Method Income | €25.0M | €21.0M |
| YoY % | -16.0% | |
| Pretax Income | €389.0M | €352.0M |
| YoY % | -9.5% | |
| Income Tax | €192.0M | €357.0M |
| YoY % | +85.9% | |
| Net Income (incl. NCI) | €197.0M | -€5.0M |
| Minority Interest (P&L) | €3.0M | €0 |
| YoY % | -100.0% | |
| Net Income | €193.0M | -€5.0M |
| EPS (Basic) | €1.83 | -€0.05 |
| EPS (Diluted) | €1.82 | -€0.05 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
